Skip to main content

Macarena Simon-Talero Horga

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Macarena Simon-Talero Horga

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Research lines

Cirrosis i malalties vasculars hepàtiques

Trombosis portal

Malalties vasculars porto-sinusoïdals

Hipertensió portal

Encefalopatia hepàtica

IP: Macarena Simon-Talero Horga

Projects

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Malalties hepàtiques, Maria Buti Ferret, Montserrat Gomez Perez, Malalties hepàtiques, Judit Vico Romero, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Daniel Martinez Vazquez, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, Malalties hepàtiques, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano, Malalties hepàtiques
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

Determinación de biomarcadores de lesión neuronal y astrocitaria en suero de paciente con encefalopatía hepática

IP: Macarena Simon-Talero Horga
Collaborators: Determinación de biomarcadores de lesión neuronal y astrocitaria en suero de paciente con encefalopatía hepática, Joaquin Castillo Justribo, Mònica Pons Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 60500
Reference: PI21/00312
Duration: 01/01/2022 - 31/12/2024

Desarrollo de nuevas terapias basadas en microbiota intestinal mediante un enfoque polifásico (cultivo + ómicas) para el tratamiento de la hipertensión portal en esteatohepatitis no alcohólica

IP: Macarena Simon-Talero Horga
Collaborators: Ariadna Rando Segura
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI17/00310
Duration: 01/01/2018 - 30/06/2021

Sol·licitud Juan Rodés.

IP: Joan Genescà Ferrer
Collaborators: Macarena Simon-Talero Horga
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR17/00029
Duration: 01/01/2018 - 24/07/2022

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

Clara Palmada Ibars

Clara Palmada Ibars

Shock, Organ Dysfunction and Resuscitation
Read more
Anna Deàs Just

Anna Deàs Just

Predoctoral researcher
Diabetes and Metabolism
Read more
Carlos Ernesto Marrero Eligio de la Puente

Carlos Ernesto Marrero Eligio de la Puente

Administration and Management
Neurovascular Diseases
Read more
Sara Escalera Anzola

Sara Escalera Anzola

Predoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.